OEM HRD Pharm Manufacturer for 720720-96-7: Quality & Reliability
Dipeptidyl peptidase-4 (DPP-inhibitor with the CAS number 720720-96-7, offers a significant advancement in the management of type 2 diabetes. This innovative compound, developed by Zhuhai HRD Pharm Co., Ltd., plays a crucial role in enhancing glucose control by inhibiting the enzyme DPP-4, which is responsible for breaking down incretin hormones. By preserving these hormones, it promotes insulin secretion in response to meals while reducing glucagon levels, ultimately leading to improved blood sugar regulation, With its unique mechanism of action, this product demonstrates favorable efficacy and safety profiles, making it a valuable addition to diabetes therapy regimens. Zhuhai HRD Pharm Co., Ltd. is dedicated to providing high-quality pharmaceuticals, ensuring that patients receive effective and reliable treatment options. Committed to excellence, the company prioritizes research and development, contributing to better health outcomes for individuals managing diabetes. Experience the potential of this cutting-edge therapeutic agent in transforming diabetes care
![2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetamide](https://ecdn6-nc.globalso.com/upload/p/2809/image_product/2024-12/503155-67-7-2-butyl-1-6-dihydro-n-n-4-trimethyl-6-oxo-1-2-1-triphenylmethyl-1h-tetrazol-5-yl-1-1-biphenyl-4-yl-methyl-5-pyrimidineacetamide.jpg)
![(S)-2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine](https://ecdn6-nc.globalso.com/upload/p/2809/image_product/2024-12/190786-43-7-s-2-4-chlorophenyl-4-piperidinyloxy-methyl-pyridine.jpg)
